疑诊急性冠脉综合征患者的高敏肌钙蛋白性别特异性阈值
该研究在10家医院开展阶梯楔形整群随机对照试验,纳入48,282例疑诊急性冠脉综合征患者(47%为女性),评估采用性别特异性高敏肌钙蛋白I诊断阈值对心肌梗死诊断及预后的影响。结果显示,采用性别特异性阈值使女性心肌损伤检出增加42%、男性增加6%,但女性接受冠脉血运重建和预防性治疗的比例仍显著低于男性,1年主要结局未改善。
要点
- 性别特异性高敏肌钙蛋白I阈值使女性心肌损伤检出增加42%,男性增加6%。
- 实施后女性心肌损伤患者接受血运重建(15% vs 34%)和双联抗血小板(26% vs 43%)等治疗仍显著少于男性。
- 女性心肌损伤患者1年主要结局在实施前后无显著改善(调整HR 1.11,95%CI 0.92-1.33)。
核心结论
- 采用性别特异性高敏肌钙蛋白I阈值检出心肌损伤的女性增加数量约为男性的5倍,但女性接受冠心病治疗的比例仍约为男性的一半,且结局未改善。
研究设计与样本
- 阶梯楔形整群随机对照试验,纳入10家医院连续疑诊急性冠脉综合征患者共48,282例(47%为女性)。
- 心肌损伤定义为高敏肌钙蛋白I浓度超过女性16 ng/l、男性34 ng/l的第99百分位。
- 主要结局为1年内再发心肌梗死或心血管死亡。
主要发现
- 采用性别特异性阈值后,女性心肌损伤检出增加42%,男性增加6%。
- 实施后女性心肌损伤患者接受冠脉血运重建比例为15%,男性为34%;双联抗血小板治疗女性26%、男性43%;他汀治疗女性16%、男性26%(所有p < 0.001)。
- 女性心肌损伤患者主要结局在实施前为18%(369/2,072)、实施后为17%(488/2,919),调整HR 1.11(95%CI 0.92-1.33)。
- 男性心肌损伤患者主要结局在实施前为18%(370/2,044)、实施后为15%(513/3,325),调整HR 0.85(95%CI 0.71-1.01)。
关键数值与推荐
- 心肌损伤诊断阈值:女性高敏肌钙蛋白I >16 ng/l,男性 >34 ng/l(第99百分位)。
临床怎么用
- 临床应采用性别特异性高敏肌钙蛋白I阈值以提高女性心肌损伤的识别。
- 识别心肌损伤后需关注女性患者治疗不足的问题,确保按指南给予血运重建和预防性药物治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Major disparities between women and men in the diagnosis, management, and outcomes of acute coronary syndrome are well recognized. OBJECTIVES: The aim of this study was to evaluate the impact of implementing a high-sensitivity cardiac troponin I assay with sex-specific diagnostic thresholds for myocardial infarction in women and men with suspected acute coronary syndrome. METHODS: Consecutive patients with suspected acute coronary syndrome were enrolled in a stepped-wedge, cluster-randomized controlled trial across 10 hospitals. Myocardial injury was defined as high-sensitivity cardiac troponin I concentration >99th centile of 16 ng/l in women and 34 ng/l in men. The primary outcome was recurrent myocardial infarction or cardiovascular death at 1 year. RESULTS: A total of 48,282 patients (47% women) were included. Use of the high-sensitivity cardiac troponin I assay with sex-specific thresholds increased myocardial injury in women by 42% and in men by 6%. Following implementation, women with myocardial injury remained less likely than men to undergo coronary revascularization (15% vs. 34%) and to receive dual antiplatelet (26% vs. 43%), statin (16% vs. 26%), or other preventive therapies (p < 0.001 for all). The primary outcome occurred in 18% (369 of 2,072) and 17% (488 of 2,919) of women with myocardial injury before and after implementation, respectively (adjusted hazard ratio: 1.11; 95% confidence interval: 0.92 to 1.33), compared with 18% (370 of 2,044) and 15% (513 of 3,325) of men (adjusted hazard ratio: 0.85; 95% confidence interval: 0.71 to 1.01). CONCLUSIONS: Use of sex-specific thresholds identified 5 times more additional women than men with myocardial injury. Despite this increase, women received approximately one-half the number of treatments for coronary artery disease as men, and outcomes were not improved. (High-Sensitivity Troponin in the Evaluation of Patients With Acute Coronary Syndrome [High-STEACS]; NCT01852123).
引用
- Lee KK, Ferry AV, Anand A, et al. Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome. J Am Coll Cardiol. 2019. PMID: 31623760. doi:10.1016/j.jacc.2019.07.082
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。